CTSI Update: Reminders
BU CTSI Support for Affymetrix Microarray
or RNA Sequencing Experiments
Application Deadline: Mar. 11, 2022

Funding available to support translational research through subsidies that cover part of the cost of RNA sequencing projects in the BU Microarray and Sequencing Resource and the Single-Cell Sequencing Core. Learn More
The BU CTSI Voucher Program
Applications are Accepted on a Rolling Basis.

The Voucher Program supports the short-term needs of investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, generate data for new or ongoing projects, and/or secure fee-based core services for expert consultation services. Learn More
The 2021 BU CTSI Impact:
Noteworthy Achievements, Accomplishments, & Success Stories

"Our focus is improving the health of structurally marginalized populations. We strive to bridge the gaps across disciplines, schools, and departments to yield the very best translational science and translational research. Diversity, equity and inclusion are core values of our Institute including recognizing the value of a diverse workforce and leadership, ensuring deep community partnerships, and developing strategies to engage diverse populations as research participants." Access Online Report Here
Funding Opportunities

BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)

National Institute of Neurological Disorders and Stroke (NINDS)

Notice of Special Interest (NOSI): Developing Digital Therapeutics for Substance Use Disorders


Notice of Special Interest (NOSI): Public Health Research on Cannabis

National Institute on Drug Abuse (NIDA)

Notice of Special Interest (NOSI): Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supplements)

National Center for Complementary and Integrative Health (NCCIH)

Notice of Special Interest (NOSI): Postmortem Pathology, Cellular, and Molecular Analyses to Determine the Significance of White Matter Lesions and other Imaging Findings of Presumed Vascular Origin During Life

National Institute of Neurological Disorders and Stroke (NINDS)

Notice of Special Interest (NOSI): CCRP Administrative Supplement for Collaborative Science to Synergize Chemical Medical Countermeasures Discovery and Early Development

National Institute of Allergy and Infectious Diseases (NIAID)

Notice of Special Interest (NOSI): Optimizing Vascularized Composite Allograft Survival

National Institute of Allergy and Infectious Diseases (NIAID)

Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)


Emergency Awards: RADx®-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)

Office of The Director, National Institutes of Health (OD)

Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)

National Center for Advancing Translational Sciences (NCATS)
News Highlights

How COVID-19 Immunity Holds Up Over Time

The researchers explored in the lab how neutralizing antibodies within those serum samples reacted to SARS-CoV-2 pseudo viruses representing each of the five variants. Read More
Scientists Pinpoint Mechanisms Associated with Severe COVID-19 Blood Clotting

Scientists compared the blood samples to those from healthy controls and found the COVID-19 samples contained higher levels of the antibody IgG, which works with other immune cells, such as IgM, to respond to immune threats. Read More
Upcoming Event
The Individualizing Therapy for High-Risk Early-Stage Hormone
Receptor-Positive Breast Cancer
Mar. 5, 2022, 7:00 AM – 8:30 am

The focus will be on the integration of clinical and molecular factors for risk assessment and ways that recent clinical data with endocrine regimens integrating CDK4/6 inhibitors have shifted treatment paradigms and expanded treatment options. Read More
The Funding Acknowledgement
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.